ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
Great Elm Capital Corporation

Great Elm Capital Corporation (GECCN)

25,20
0,00
( 0,00% )
Aktualisiert: 01:00:00

Professionelle Tools für Privatanleger.

Wichtige Statistiken und Details

Current Price
25,20
Gebot
21,61
Fragen
26,42
Volumen
-
0,00 Tagesbereich 0,00
0,00 52-Wochen-Bereich 0,00
Marktkapitalisierung
Handelsende
25,20
Handelsbeginn
-
Letzte Trade
Letzter Handelszeitpunkt
-
Finanzvolumen
-
VWAP
-
Durchschnittliches Volumen (3 Mio.)
-
Ausgegebene Aktien
7.602.000
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
7,50
Gewinn pro Aktie (EPS)
3,33
Erlöse
35,83M
Nettogewinn
25,33M

Über Great Elm Capital Corporation

Sektor
Unit Inv Tr, Closed-end Mgmt
Branche
Unit Inv Tr, Closed-end Mgmt
Hauptsitz
Lutherville Timonium, Maryland, USA
Gegründet
-

GECCN Neueste Nachrichten

Great Elm Capital Corp. Announces Conditional Redemption of 6.50% Notes due 2024

WALTHAM, Mass., Aug. 08, 2023 (GLOBE NEWSWIRE) -- Great Elm Capital Corp. (the “Company” or “GECC”) (NASDAQ: GECC) announced today that it has caused notices to be issued to the holders of its...

Great Elm Capital Corp. Announces Second Quarter 2023 Financial Results

WALTHAM, Mass., Aug. 03, 2023 (GLOBE NEWSWIRE) -- Great Elm Capital Corp. (“we,” “our,” the “Company” or “GECC,”) (NASDAQ: GECC), a business development company, today announced its financial...

Great Elm Capital Corp. Announces First Quarter 2023 Financial Results

WALTHAM, Mass., May 04, 2023 (GLOBE NEWSWIRE) -- Great Elm Capital Corp. (“we,” “our,” the “Company” or “GECC,”) (NASDAQ: GECC), a business development company, today announced its financial...

Great Elm Capital Corp. Announces Fourth Quarter and Full Year 2022 Financial Results

WALTHAM, Mass., March 02, 2023 (GLOBE NEWSWIRE) -- Great Elm Capital Corp. (“we,” “our,” the “Company” or “GECC,”) (NASDAQ: GECC), a business development company, today announced its financial...

Great Elm Capital Corp. Announces Third Quarter 2022 Financial Results

WALTHAM, Mass., Nov. 03, 2022 (GLOBE NEWSWIRE) -- Great Elm Capital Corp. (“we,” “us,” “our,” the “Company” or “GECC,”) (NASDAQ: GECC), a business development company, today announced its...

Great Elm Capital Corp. Announces Second Quarter 2022 Financial Results

WALTHAM, Mass., Aug. 04, 2022 (GLOBE NEWSWIRE) -- Great Elm Capital Corp. (“we,” “us,” “our,” the “Company” or “GECC,”) (NASDAQ: GECC), a business development company, today announced its...

Great Elm Capital Corp. Announces First Quarter 2022 Financial Results

WALTHAM, Mass., May 11, 2022 (GLOBE NEWSWIRE) -- Great Elm Capital Corp. (“we,” “us,” “our,” the “Company” or “GECC”) (NASDAQ: GECC), a business development company, today announced its...

Great Elm Capital Corp. Announces Fourth Quarter and Full Year 2021 Financial Results

Company to Host Quarterly Conference Call and Webcast at 11:00 AM ET Today WALTHAM, Mass., March 04, 2022 (GLOBE NEWSWIRE) -- Great Elm Capital Corp. (“we,” “us,” “our,” the “Company” or...

Great Elm Capital Corp. Announces First Quarter 2021 Financial Results Highlighted By 12.4% Increase in Nav Per Share

WALTHAM, Mass., May 07, 2021 (GLOBE NEWSWIRE) -- Great Elm Capital Corp. (“we,” “us,” “our,” or “GECC,”) (NASDAQ: GECC), a business development company, today announced its financial results for...

Great Elm Capital Corp. Announces Fourth Quarter 2020 Financial Results Highlighted by Net Investment Income of $0.07 Per Sha...

WALTHAM, Mass., March 16, 2021 (GLOBE NEWSWIRE) -- Great Elm Capital Corp. (“we,” “us,” “our,” or “GECC,”) (NASDAQ: GECC), a business development company, today announced its financial results...

Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
10000000CS
40000000CS
120000000CS
260000000CS
520000000CS
1560000000CS
2600000000CS

GECCN - Frequently Asked Questions (FAQ)

What is the current Great Elm Capital share price?
The current share price of Great Elm Capital is US$ 25,20
How many Great Elm Capital shares are in issue?
Great Elm Capital has 7.602.000 shares in issue
What is the market cap of Great Elm Capital?
The market capitalisation of Great Elm Capital is USD 191,57M
What is the 1 year trading range for Great Elm Capital share price?
Great Elm Capital has traded in the range of US$ 0,00 to US$ 0,00 during the past year
What is the PE ratio of Great Elm Capital?
The price to earnings ratio of Great Elm Capital is 7,5
What is the cash to sales ratio of Great Elm Capital?
The cash to sales ratio of Great Elm Capital is 5,3
What is the reporting currency for Great Elm Capital?
Great Elm Capital reports financial results in USD
What is the latest annual turnover for Great Elm Capital?
The latest annual turnover of Great Elm Capital is USD 35,83M
What is the latest annual profit for Great Elm Capital?
The latest annual profit of Great Elm Capital is USD 25,33M
What is the registered address of Great Elm Capital?
The registered address for Great Elm Capital is 2405 YORK RD, STE 201, LUTHERVILLE TIMONIUM, MARYLAND, 21093
What is the Great Elm Capital website address?
The website address for Great Elm Capital is www.greatelmcc.com
Which industry sector does Great Elm Capital operate in?
Great Elm Capital operates in the UNIT INV TR, CLOSED-END MGMT sector
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
SLXNSilexion Therapeutics Corporation
US$ 1,22
(110,34%)
167M
YIBOPlanet Image International Ltd
US$ 5,095
(65,42%)
46,95M
RNAZTransCode Therapeutics Inc
US$ 10,87
(59,15%)
14,04M
BACKIMAC Holdings Inc
US$ 1,1708
(41,23%)
51,99M
TRIBTrinity Biotech PLC
US$ 1,06
(39,47%)
97,64M
LPTXLeap Therapeutics Inc
US$ 0,6652
(-70,44%)
7,28M
STSSSharps Technology Inc
US$ 0,45555
(-68,80%)
10,92M
SABSSAB Biotherapeutics Inc
US$ 2,156
(-50,55%)
872,97k
MGOLMGO Global Inc
US$ 0,1791
(-36,71%)
13,51M
INKTMiNK Therapeutics Inc
US$ 6,60
(-25,33%)
28,8k
HEPAHepion Pharmaceuticals Inc
US$ 0,2138
(29,58%)
224,97M
NVDANVIDIA Corporation
US$ 120,6001
(1,84%)
217,94M
SLXNSilexion Therapeutics Corporation
US$ 1,2103
(108,67%)
167,08M
TNXPTonix Pharmaceuticals Holding Corporation
US$ 0,503
(22,06%)
101,07M
TRIBTrinity Biotech PLC
US$ 1,0699
(40,78%)
97,64M
Keine Diskussionen Gefunden.
Neuen Thread Erstellen